Among the classifications of breast cancer, TNBC, manifested as early recurrence and poor survival, does not express estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast cancer.